Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
Researchers call for greater use of noninvasive measures of fatty liver disease in this population to identify those at risk.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
Experts are not certain what this latest trend signifies for the trajectory of the opioid use disorder epidemic, however.
New cases of all three viruses have declined in the city over the past decade.
In the era of highly effective treatments for both viruses, HIV doesn’t speed the advancement of cirrhosis.
A long-term study also found that superinfection—acquiring a second strain of HIV—was not a risk for the transplantees.
The opioid epidemic is principally responsible for a recent increase in infective endocarditis in the United States.
The indication for AbbVie’s regimen includes those with compensated cirrhosis.
Pharmacist-driven hep C treatment sees good cure rates
However, the presence of such persistent virus has not been found to be associated with liver damage.
Inflammation in people with HIV is associated with cardiovascular disease and other serious health conditions.
Researchers analyzed autopsies among people with HIV who died in New York City since 1984.
Researchers analyzed the association between heavy drinking and immune function in those with untreated HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.